The PENTHELA brand, founded in 2013 (United States), from 13 sister brands and 2214 competing brands. The PENTHELA brand is owned by Lexicon Pharmaceuticals, a company listed in New York. PENTHELA is part of the Biotechnology activity sector.

PENTHELA is a brand of Lexicon Pharmaceuticals (LXRX) Share price

Share price and profitability of the share Lexicon Pharmaceuticals (PENTHELA)

Buy Lexicon Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 2.19

Portfolio valuation
Lexicon Pharmaceuticals (PENTHELA) over 5 years* USD 0.87

Stock market history Lexicon Pharmaceuticals (PENTHELA)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more